Gateway Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.09M Sell
1,228
-34
-3% -$30.6K 0.18% 57
2024
Q2
$1.14M Buy
1,262
+47
+4% +$37.6K 0.19% 56
2024
Q1
$945K Buy
1,215
+467
+62% +$332K 0.17% 58
2023
Q4
$436K Buy
+748
New +$437K 0.08% 74
2023
Q1
Sell
-1,801
Closed -$659K 101
2022
Q4
$659K Buy
1,801
+46
+3% +$16.3K 0.17% 47
2022
Q3
$567K Buy
+1,755
New +$556K 0.14% 48

Other funds holding LLY

Gateway Advisory's LLY Position: Q3 2024 in Review

Gateway Advisory reduced its Eli Lilly (LLY) stake by 2.7% in Q3 2024, selling an estimated $30.6K and leaving 1,228 shares worth $1.09M. The position accounts for 0.18% of the portfolio, ranked #57.

Gateway Advisory first reported a position in LLY in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.14M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Gateway Advisory held 1,228 shares of Eli Lilly worth $1.09M as of Q3 2024.
  • Gateway Advisory sold 34 Eli Lilly shares in Q3 2024, an estimated $30.6K.
  • Eli Lilly made up 0.18% of Gateway Advisory's portfolio in Q3 2024, its #57 holding.
  • Gateway Advisory first reported a position in Eli Lilly in Q3 2022 and has held it in 6 quarters since.
  • Gateway Advisory's Eli Lilly position peaked at $1.14M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Gateway Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.